Time course of phosphorylated tau181 in blood across the Alzheimer’s disease spectrum
Alexis Moscoso, Michel J. Grothe, Nicholas J. Ashton, Thomas K. Karikari, Juan Lantero Rodriguez, Anniina Snellman, View ORCID ProfileMarc Suárez-Calvet, Henrik Zetterberg, Kaj Blennow, View ORCID ProfileMichael Schöll, for the Alzheimer’s Disease Neuroimaging Initiative
doi: https://doi.org/10.1101/2020.07.13.20152025
Alexis Moscoso
1Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sweden
2Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Sweden
Michel J. Grothe
1Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sweden
2Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Sweden
3Unidad de Trastornos del Movimiento, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain
Nicholas J. Ashton
1Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sweden
2Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Sweden
4King’s College London, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute, London, UK
5NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation, London, UK
Thomas K. Karikari
1Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sweden
Juan Lantero Rodriguez
1Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sweden
Anniina Snellman
1Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sweden
6Turku PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland
Marc Suárez-Calvet
7Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation. Barcelona, Spain
8IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
9Servei de Neurologia, Hospital del Mar, Barcelona, Spain
10Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain
Henrik Zetterberg
1Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sweden
11Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
12Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK
13UK Dementia Research Institute at University College London, London, UK
Kaj Blennow
1Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sweden
11Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
Michael Schöll
1Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sweden
2Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Sweden
12Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK
Posted July 14, 2020.
Time course of phosphorylated tau181 in blood across the Alzheimer’s disease spectrum
Alexis Moscoso, Michel J. Grothe, Nicholas J. Ashton, Thomas K. Karikari, Juan Lantero Rodriguez, Anniina Snellman, Marc Suárez-Calvet, Henrik Zetterberg, Kaj Blennow, Michael Schöll, for the Alzheimer’s Disease Neuroimaging Initiative
medRxiv 2020.07.13.20152025; doi: https://doi.org/10.1101/2020.07.13.20152025
Time course of phosphorylated tau181 in blood across the Alzheimer’s disease spectrum
Alexis Moscoso, Michel J. Grothe, Nicholas J. Ashton, Thomas K. Karikari, Juan Lantero Rodriguez, Anniina Snellman, Marc Suárez-Calvet, Henrik Zetterberg, Kaj Blennow, Michael Schöll, for the Alzheimer’s Disease Neuroimaging Initiative
medRxiv 2020.07.13.20152025; doi: https://doi.org/10.1101/2020.07.13.20152025
Subject Area
Subject Areas
- Addiction Medicine (379)
- Allergy and Immunology (694)
- Anesthesia (186)
- Cardiovascular Medicine (2806)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12492)
- Forensic Medicine (10)
- Gastroenterology (796)
- Genetic and Genomic Medicine (4360)
- Geriatric Medicine (397)
- Health Economics (710)
- Health Informatics (2809)
- Health Policy (1041)
- Hematology (372)
- HIV/AIDS (888)
- Medical Education (410)
- Medical Ethics (113)
- Nephrology (458)
- Neurology (4127)
- Nursing (219)
- Nutrition (612)
- Oncology (2178)
- Ophthalmology (616)
- Orthopedics (253)
- Otolaryngology (315)
- Pain Medicine (260)
- Palliative Medicine (80)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (478)
- Public and Global Health (6719)
- Radiology and Imaging (1475)
- Respiratory Medicine (893)
- Rheumatology (427)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (197)
- Urology (173)